The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Shire plc

  • SHPG
  • NASDAQ
  • Consumer Products
  • Latest 97.04
  • Currency US$
  • Change 0.10
  • Percent Change 0.103 %
  • Volume 1,006,332
  • Wed May 22, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 96.57
  • Previous Close 96.94
  • High 97.56
  • Low 96.41
  • Bidx --
  • Askx --
  • 52-week High -- 102.04
  • 52-week Low -- 80.09
  • Beta 0.535
  • Market Cap 18,195.97M
  • EPS --
  • P/E --
  • Forward P/E 12.752
  • PEG 1.46
  • Annual Dividend 0.876
  • Yield 0.903

News

Financials & Calendars

Income Statement

  • Sales $4,681,200,000
  • Earnings $745,400,000
  • Return on Equity 19.39%

Cash Flow

  • Cash Flow --
  • Cash $1,482,200,000
  • Current Ratio 1.95

12 months ended Dec 31, 2012.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $7,317,200,000
  • Liabilities $3,508,000,000
  • Liabilities-to-Equity Ratio 0.92

Price Ratios

  • Price to Sales 3.88
  • Price to Book 4.77
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings May 2 $1.61 Aug 7 $1.65
Surprises May 2 1.24% n/a n/a
Dividends Mar 6 $0.44 n/a n/a
Splits n/a -- n/a n/a

12 months ended May 22, 2013.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)

Related Securities
Symbol Type Latest % Chg

Officers

  • Matthew Emmens Non-executive Chairman
  • Angus Russell Chief Executive Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

HAMPSHIRE INTL BUSINESS PARK C
HAMPSHIRE ENGLAND RG, X0
R924 8E

investorrelations@shire.com
www.shire.com

Ideas & Discussion

Live Discussion of SHPG on StockTwits